Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
M.D. Anderson Cancer Center
Primary Objectives: 1. To evaluate the safety of tiragolumab + atezolizumab + RadScopal™ XRT (Phase I). 2. To evaluate the efficacy of tiragolumab + atezolizumab + RadScopal™ XRT (Phase Ib). Secondary Objectives: 1. To compare the efficacy of tiragolumab + atezolizumab + RadScopal™ XRT to tiragolumab + atezolizumab and atezolizumab + RadScopal™ XRT. 2. To evaluate time-to-event outcomes of tiragolumab + atezolizumab + RadScopal™ XRT.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted